Danaher Corporation (DHR) : Mackenzie Financial Corp reduced its stake in Danaher Corporation by 2.06% during the most recent quarter end. The investment management company now holds a total of 2,207,993 shares of Danaher Corporation which is valued at $215 Million after selling 46,548 shares in Danaher Corporation , the firm said in a disclosure report filed with the SEC on May 12, 2016.Danaher Corporation makes up approximately 1.98% of Mackenzie Financial Corp’s portfolio.
Other Hedge Funds, Including , Eaton Vance Management reduced its stake in DHR by selling 102,162 shares or 10.09% in the most recent quarter. The Hedge Fund company now holds 910,619 shares of DHR which is valued at $88.7 Million. Danaher Corporation makes up approx 0.27% of Eaton Vance Management’s portfolio.Blackrock Investment Management reduced its stake in DHR by selling 32,417 shares or 2.81% in the most recent quarter. The Hedge Fund company now holds 1,119,240 shares of DHR which is valued at $109 Million. Danaher Corporation makes up approx 0.14% of Blackrock Investment Management’s portfolio.Fulton Breakefield Broenniman reduced its stake in DHR by selling 534 shares or 0.62% in the most recent quarter. The Hedge Fund company now holds 85,385 shares of DHR which is valued at $8.3 Million. Danaher Corporation makes up approx 1.84% of Fulton Breakefield Broenniman’s portfolio. Winton Capital Group Ltd added DHR to its portfolio by purchasing 129,049 company shares during the most recent quarter which is valued at $12.5 Million. Danaher Corporation makes up approx 0.14% of Winton Capital Group Ltd’s portfolio.Tirschwell Loewy Inc reduced its stake in DHR by selling 210 shares or 0.08% in the most recent quarter. The Hedge Fund company now holds 250,896 shares of DHR which is valued at $24.3 Million. Danaher Corporation makes up approx 4.23% of Tirschwell Loewy Inc’s portfolio.
Danaher Corporation opened for trading at $98.44 and hit $99.4 on the upside on Friday, eventually ending the session at $98.75, with a gain of 0.80% or 0.78 points. The heightened volatility saw the trading volume jump to 23,94,109 shares. Company has a market cap of $68,009 M.
On the company’s financial health, Danaher Corporation reported $1.08 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Apr 21, 2016. Analyst had a consensus of $1.03. The company had revenue of $5387.20 million for the quarter, compared to analysts expectations of $5329.83 million. The company’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.93 EPS.
Investors should note that on May 10, 2016, Danaher Corporation announced a cash dividend of $0.1600. The company’s management has announced Jun 1, 2016 as the ex-dividend date and fixed the record date on Jun 3, 2016. The payable date has been fixed on Jul 29, 2016.
Many Wall Street Analysts have commented on Danaher Corporation. Company shares were Reiterated by RBC Capital Mkts on Apr 22, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 96 from a previous price target of $87 .Company shares were Reiterated by Stifel on Apr 22, 2016 to “Buy”, Firm has raised the Price Target to $ 110 from a previous price target of $109 .Company shares were Reiterated by Barclays on Apr 22, 2016 to “Overweight”, Firm has raised the Price Target to $ 105 from a previous price target of $104 .
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.